Target intelligence / Profile preview

ECI2 divergent transcript (ECI2-DT)

Target
ECI2-DT
Molecular classification
lncRNA, long non-coding RNA
01

Overview

ECI2 divergent transcript (ECI2-DT) is a long non-coding RNA (lncRNA) gene, meaning its transcript does not encode a protein product. It is classified as an RNA gene affiliated with the lncRNA class, as indicated in gene resources. The term "divergent transcript" typically denotes a non-coding RNA transcribed from the genomic region adjacent to, and on the opposite DNA strand from, a protein-coding gene—in this case, the ECI2 gene (enoyl-CoA delta isomerase 2). There are currently no data supporting a direct biological function, disease relevance, or interaction with drugs for ECI2-DT. No evidence suggests it plays a role as a therapeutic target, receptor, enzyme, transporter, or any such actionable molecular entity. It most likely serves a regulatory RNA function in the context of genome transcription, but any distinct roles remain undefined. ECI2-DT is not the same as the protein-coding gene ECI2 (Enoyl-CoA delta isomerase 2), which is a mitochondrial enzyme involved in fatty acid metabolism. ECI2-DT is only an associated non-coding transcript and not a candidate for pharmacological targeting or direct therapeutic intervention. The term "divergent transcript" generally refers to non-coding RNAs produced by divergent transcription from promoters, often resulting in lncRNAs. ECI2-DT is catalogued in genomic databases as an lncRNA but lacks robust functional or disease-association data.

Other names
ECI2-DTECI2 divergent transcript
02

Biological functions

Unknown; likely regulatory (based on general lncRNA roles)Likely serves a regulatory RNA function in the context of genome transcription, but any distinct roles remain undefined.
03

Disease associations

Unknown; no direct evidence as a disease gene or biomarker

Beyond the preview

Go deeper on ECI2 divergent transcript (ECI2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ECI2 divergent transcript (ECI2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call